Abstract
We present a case history of a woman who developed dermatomyositis following the diagnosis of stage IV ovarian cancer. Dermatomyositis is a rare paraneoplastic syndrome that usually precedes the diagnosis of ovarian cancer by several months or years. Ours is the fifth reported case of dermatomyositis after an established diagnosis of ovarian cancer in the literature.
MeSH terms
-
Aged
-
Antineoplastic Agents / administration & dosage
-
Biomarkers, Tumor / blood
-
CA-125 Antigen / blood
-
Dermatomyositis / drug therapy
-
Dermatomyositis / etiology*
-
Disease Progression
-
Fatal Outcome
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Neoadjuvant Therapy
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Staging
-
Ovarian Neoplasms / blood
-
Ovarian Neoplasms / complications
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / pathology*
-
Paraneoplastic Syndromes / drug therapy
-
Paraneoplastic Syndromes / etiology*
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
CA-125 Antigen
-
Immunosuppressive Agents